| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:79884368:1310 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:79884368:1310?format=raw |
LEADER: 01310mam a2200337 4500
001 4063166
005 20221027030210.0
008 810714s1963 enka b 000 0 eng d
015 $aGB63-16445
035 $a(OCoLC)7584696
035 $a(OCoLC)ocm07584696
035 $a(CStRLIN)ILCGHZ3447421-B
035 $a(ICU)hz3447421
035 $9AQX6722HS
035 $a(NNC)4063166
035 $a4063166
040 $aCUX$cCUX$dUKM$dCGU$dCStRLIN$dNNC-M
082 04 $a616.85$218
100 1 $aLing, T. M.$0http://id.loc.gov/authorities/names/nr92007006
245 10 $aLysergic acid (LSD 25) & ritalin in the treatment of neurosis /$c[by] Thomas M. Ling [and] John Buckman.
260 $a[London] :$bLambarde Press,$c[1963]
300 $a172 pages :$bb illustrations ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aBibliographical footnotes.
650 2 $aLysergic Acid Diethylamide$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D008238Q000627
650 2 $aMethylphenidate$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D008774Q000627
650 2 $aPsychotherapy.$0https://id.nlm.nih.gov/mesh/D011613
650 2 $aNeurotic Disorders$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009497Q000188
700 1 $aBuckman, John.
852 00 $boff,hsl$hRC483.5$i.L64 1963